molecules of the month

Merck IDO1 inhibitor

heme-displacing IDO1 inhibitor

human predicted QD dose of 26 mg

from 260k MS-based screen and SBDD

ACS Med. Chem. Lett. Mar. 10, 2020

Merck, Boston, MA

Merck IDO1 inhibitor
1 min read

Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: